Med. praxi. 2026;23(2):112-117 | DOI: 10.36290/med.2026.013

Management of gastroesophageal reflux disease - up to date

MUDr. Lucie Zdrhová1, 2, MUDr. Karel Balihar, Ph.D.1
1 Oddělení gastroenterologie hepatologie, I. interní klinika FN LF UK Plzeň
2 Centrum pohybové medicíny Pavla Koláře, Praha

Gastroesophageal reflux disease (GERD) is one of the most common diseases encountered by both primary care physicians and gastroenterologists in their specialized outpatient clinics. Reflux symptoms such as heartburn, regurgitation, or chest pain may indicate not only true reflux disease, but also extra-esophageal diseases, including disorders of impaired autonomic nervous system balance. The management of patients with reflux symptoms has changed significantly in recent years, mainly due to the increased use of diagnostic methods such as 24-hour pH metry with impedance, wireless esophageal pH metry, and high-resolution esophageal manometry. These functional esophageal methods play a key role in determining the etiopathogenesis of reflux symptoms and defining the phenotype of a particular patient. This allows not only to individualize treatment, but also to reduce the use of antireflux medication. Early and accurate diagnosis of reflux symptoms is crucial for modern RCHJ treatment.

Keywords: gastroesophageal reflux disease, 24-hour esophageal pH monitoring, Bravo capsule, esophageal manometry, diaphragmatic breathing.

Received: March 5, 2026; Revised: March 28, 2026; Accepted: March 31, 2026; Published: April 28, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zdrhová L, Balihar K. Management of gastroesophageal reflux disease - up to date. Med. praxi. 2026;23(2):112-117. doi: 10.36290/med.2026.013.
Download citation

References

  1. Yamasaki T, Hemond C, Eisa M, et al. The changing epidemiology of gastroesophageal reflux disease: are patients getting younger? J Neurogastroenterol Motil. 2018;24:559-69. https://doi. org/ 10. 5056/ jnm18 140. Go to original source...
  2. Gyawali CP, Yadlapati R, Fass R, et al. Update to the Modern diagnosis of GERD: Lyon consensus 2.0. Gut. 2024 Jan 5;73(2):361-371. doi: 10.1136/gutjnl-2023-330616. Go to original source... Go to PubMed...
  3. Tack J, Pandolfino JE. Pathophysiology of Gastroesophageal Reflux Disease, Gastroenterology. 2018;154:277-288. https:// doi. org/10. 1053/j. gastro. 2017. 09. 047. Go to original source...
  4. Mittal RK, Holloway RH, Penagini R, et al. Transient Lower Esophageal Sphicter Relaxation. Gastroenterology. 1995;109:601-610. Go to original source...
  5. Jandee S, Geeraerts A, Geysen H, et al. Management of Ineffective Esophageal Hypomotilit. Frontiers in Pharmacology. 2021;12:638915. https:// doi. org/ 10. 3389/ fphar. 2021. 638915. Go to original source...
  6. Anggiansah R, Sweis R, Anggiansah , et al. The Effects of Obesity on Oesophageal Function, Acid Exposure and the Symptoms of Gastro-Oesophageal Reflux Disease. Alimentary Pharmacology & Therapeutics. 2013;37(5): 555-563. https:// doi. org/10. 1111/ apt. 12208. Go to original source...
  7. Wong MW, Liu TT, Yi CH, et al. Oesophageal hypervigilance and visceral anxiety relate to reflux symptom severity and psychological distress but not to acid reflux parameters. Aliment Pharmacol Ther. 2021;54(7):923-30. Go to original source...
  8. YY Lee, JCY Wu. Management of patients with functional Heartburn. Gastroenterology 2018. https://doi.org/10.1053/j.gastro.2018.04.030. Go to original source... Go to PubMed...
  9. Numans ME, Lau J, de Wit NJ, et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Interm Med 2004;140:518-527. Go to original source...
  10. Karamonilis G, Kotsalidis G, Triantafyllou K, et al. Yield of combined impedance-pH monitoring for refractory reflux symptoms in clinical practice. J Neurogastroenterol Motil. 2011 Apr;17(2):158-63. doi: 10.5056/jnm.2011.17.2.158. Epub 2011 Apr 27. Go to original source... Go to PubMed...
  11. Hashimoto H, et al. Prolonged wireless pH monitoring increases diagnostic yield in patients with reflux symptoms and borderline 24-hour impedance pH. Dis of the Esophagus, 2025. Go to original source...
  12. Siboni S, Sozzi M, Kristo I, et al. The Milan score: A novel manometric tool for a more efficient diagnosis of gastro-esophageal reflux disease. UnitedEuropeanGastroenterol J. 2024;12:552-561. Go to original source...
  13. Fox M, Gyawali P. Dietary factors involved in GERD management.Best Practice and Research Clinical Gastroenetrology 2023;62-63,101826. doi.org/10.1016/j.bpg.2023.101826 . Go to original source...
  14. Ness-Jensen E, Lindam A, Lagergren J, et al. Weight loss and reduction in gastroesophageal reflux. A prospective population-based cohort study: the HUNT study. Am J Gastroenterol 2013;108:376-382. Go to original source...
  15. Ness-Jensen E, Lindam A, Lagergren J, et al. Tobacco smoking cessation and improved gastroesophageal reflux: a prospective population-based cohort study. The HUNT study. Am J Gastroenterol. 2014;109:171-177. Go to original source...
  16. Schnoll-Sussman F, Niec R, Katz PO. Proton Pump Inhibitors: The Good, Bad, and Ugly. Gastrointest Endosc Clin N Am. 2020 Apr;30(2):239-251. Go to original source...
  17. Targovnik LA, Fisher DA, Saini SD. AGA Clinical ractice Update of De-Prescribing Proton Pump Inhibitors: Expert Review. Gastroenterology. 2022;162:1334-1342 https://doi.org/10.1053/j.gastro.2021.12.247. Go to original source...
  18. Fass R, Zerbib F, Gyawali CP. AGA Clinical Practice Update on Functional Heartburn: Expert Review. Gastroenterology. 2020;158:2286-2293. Go to original source...
  19. Yadlapati R, Kahrilas PJ, Fox M, et al. Esophageal Motility Disorders on High-Resolution Manometry: Chicago Classification Version 4.0, Neurogastroenterology and Motility. 2021;33(1):e14058. https:// doi. org/ 10. 1111/ nmo. 14058 . Go to original source...
  20. Zdrhova L, Bitnar P, Balihar K, et al. Breathing Exercises in Gastroesophageal Reflux Disease: A Systematic Review. Dysphagia. 2023;38:609-621. https:// doi. org/ 10. 1007/ s0045 5-022-10494-6. Go to original source...
  21. Botha C, Farmer AD, Nilsson M, et al. Preliminary Report: Modulation of Parasympathetic Nervous System Tone Influences Oesophageal Pain Hypersensitivit. Gut. 2015;64(4):611-617. https:// doi. org/ 10. 1136/ gutjn l-2013-306698. Go to original source...
  22. Košťálová K, Suchánek Š, Zdrhová L, et al. Endoskopická léčba refluxní nemoci jícnu pomocí radiofrekvenční energie (Stretta procedura) - ošetření prvních pacientů v České republice. Gastroent Hepatol 2022;76(3):1-8. doi: 10.48095/ccgh20221. Go to original source...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.